Is levothyroxine requirement the same for tablet and soft gel formulations?
Crossref DOI link: https://doi.org/10.1007/s12020-017-1311-8
Published Online: 2017-05-02
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Di Donna, Vincenzo
Paragliola, Rosa Maria
de Waure, Chiara
Papi, Giampaolo
Pontecorvi, Alfredo
Corsello, Salvatore Maria
License valid from 2017-05-02